AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PERCHERON FPO

0.006

+0.00120.00%

Volume:6.11M

Turnover:34.29K

Market Cap:9.13M

PE:-1.46

High:0.006

Open:0.006

Low:0.005

Close:0.005

52wk High:0.011

52wk Low:0.002

Shares:1.52B

Float Shares:816.63M

Volume Ratio:9.97

T/O Rate:0.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.004

EPS(LYR):-0.004

ROE:-54.66%

ROA:-28.90%

PB:1.21

PE(LYR):-1.46

Loading ...

Overview Company News Filings

Percheron Therapeutics Receives Firm Commitments for A$2.3 Million Institutional Placement

Percheron Therapeutics - New Shares to be Issued at A$0.005 Per Share

THOMSON REUTERS

Percheron Therapeutics - Receives Firm Commitments for A$2.3 Mln Institutional Placement

THOMSON REUTERS

Percheron Therapeutics - Ambrosini Appointed as Interim Board Member During CEO Transition Period

THOMSON REUTERS

Percheron Therapeutics Ltd-Transitional Appointment of Executive Director

THOMSON REUTERS

Percheron Therapeutics - Trading Halt Sought Pending Capital Raising to Fund Study with Vanderbilt Health

THOMSON REUTERS

Percheron Therapeutics Ltd - Vanderbilt Health to Conduct Clinical Trial of Hmbd-002 in Acute Myeloid Leukaemia

THOMSON REUTERS

Percheron Therapeutics - James Garner to Step Down as CEO and Managing Director

THOMSON REUTERS

Percheron Therapeutics Ltd-Who Selects Proposed Inn for Hmbd-002

THOMSON REUTERS

Is This Singapore Mid-Cap Stock a 10-Bagger in the Making

The Smart Investor

CEO, MD & Director of Percheron Therapeutics James Garner Buys 40% More Shares

Simply Wall St.

Percheron Therapeutics Ltd-Results of Entitlement Offer

THOMSON REUTERS

Bali Airport Records 1% Raise in Passengers During 2026 Eid Holiday

BRIEF-Percheron Therapeutics To Raise Up To A$2.2 Million

Percheron Therapeutics Ltd-Non-Renounceable Entitlement Offer

THOMSON REUTERS

Percheron Therapeutics Ltd - Issue Price Set at a$0.005 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PER.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PER.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","market":"AU","secType":"STK","nameCN":"PERCHERON FPO","latestPrice":0.006,"timestamp":1788235528417,"preClose":0.005,"halted":0,"volume":6105213,"delay":0,"changeRate":0.2,"nameEN":"PERCHERON FPO","floatShares":816628906,"shares":1522412686,"eps":-0.0041,"marketStatus":"Trading","change":0.001,"latestTime":"09-01 14:26:23 AEST","open":0.006,"high":0.006,"low":0.005,"amount":34291,"amplitude":0.2,"askPrice":0.006,"askSize":11133635,"bidPrice":0.005,"bidSize":4969331,"shortable":3,"etf":0,"ttmEps":-0.0041,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":9.968365,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PER.AU","preClose":0.005,"auctionPrice":0.006,"auctionVolume":600000,"auctionTime":1788220732635,"referenceTime":1787740203093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220732635}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","floatShares":816628906,"roa":"-28.90%","roe":"-54.66%","lyrEps":-0.0041,"volumeRatio":9.968365,"shares":1522412686,"dividePrice":0,"high":0.006,"amplitude":0.2,"preClose":0.005,"low":0.005,"week52Low":0.002,"pbRate":"1.21","psRate":"10.83","week52High":0.011,"institutionHeld":0,"latestPrice":0.006,"committee":-0.382806,"eps":-0.0041,"divideRate":0,"volume":6105213,"delay":0,"ttmEps":-0.0041,"open":0.006,"prevYearClose":0.009,"prevWeekClose":0.005,"prevMonthClose":0.005,"prevQuarterClose":0.003,"fiveDayClose":0.005,"twentyDayClose":0.003,"sixtyDayClose":0.004},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PER.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PER.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PER.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664844768","title":"Percheron Therapeutics Receives Firm Commitments for A$2.3 Million Institutional Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844768","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844768?lang=en_us&edition=fundamental","pubTime":"2026-09-01 09:30","pubTimestamp":1788226256,"startTime":"0","endTime":"0","summary":"BRIEF-Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional PlacementSept 1 (Reuters)-Percheron Therapeutics LtdPER.AX:RECEIVES FIRM COMMITMENTS FOR A$2.3 MILLION INSTITUTIONAL PLACEMENTNEW SHARES TO BE ISSUED AT A$0.005 PER SHAREFurther company coverage:PER.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44S10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864588","title":"Percheron Therapeutics - New Shares to be Issued at A$0.005 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864588?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:23","pubTimestamp":1788218624,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S10I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664430886","title":"Percheron Therapeutics - Receives Firm Commitments for A$2.3 Mln Institutional Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664430886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664430886?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:23","pubTimestamp":1788218624,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663207220","title":"Percheron Therapeutics - Ambrosini Appointed as Interim Board Member During CEO Transition Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2663207220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663207220?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:22","pubTimestamp":1788160934,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE1XKSBD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020724","title":"Percheron Therapeutics Ltd-Transitional Appointment of Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020724?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:22","pubTimestamp":1788160934,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUE1XKSBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003185","title":"Percheron Therapeutics - Trading Halt Sought Pending Capital Raising to Fund Study with Vanderbilt Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003185","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003185?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:01","pubTimestamp":1787871687,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1MT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036149","title":"Percheron Therapeutics Ltd - Vanderbilt Health to Conduct Clinical Trial of Hmbd-002 in Acute Myeloid Leukaemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036149","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036149?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:11","pubTimestamp":1787868719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460369","title":"Percheron Therapeutics - James Garner to Step Down as CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460369?lang=en_us&edition=fundamental","pubTime":"2026-08-10 06:24","pubTimestamp":1786314263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260809:nFWN44600H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638568078","title":"Percheron Therapeutics Ltd-Who Selects Proposed Inn for Hmbd-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2638568078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638568078?lang=en_us&edition=fundamental","pubTime":"2026-05-26 07:22","pubTimestamp":1779751360,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUESGV1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637804468","title":"Is This Singapore Mid-Cap Stock a 10-Bagger in the Making","url":"https://stock-news.laohu8.com/highlight/detail?id=2637804468","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637804468?lang=en_us&edition=fundamental","pubTime":"2026-05-21 14:00","pubTimestamp":1779343200,"startTime":"0","endTime":"0","summary":"Finding a “10-bagger” is every investor’s dream. While most stocks never come close, some mid-cap companies possess the growth drivers, scalability, and market opportunities that could lead to outsized long-term returns.","market":"nz","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2025/09/Westlite-Mandai-Singapore-CAREIT-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2025/09/Westlite-Mandai-Singapore-CAREIT-300x200.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/is-this-singapore-mid-cap-stock-a-10-bagger-in-the-making/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/is-this-singapore-mid-cap-stock-a-10-bagger-in-the-making/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["SG9999014484.SGD","SG9999014492.USD","BK6142","BK4159","8C8U.SI","BK6139","BK6110","BK6045","BWCU.SI","BK6133","BK6082","BK6520","SG9999004311.SGD","OU8.SI","E3B.SI","BK6512","BK7096","PER.AU","CAGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628782122","title":"CEO, MD & Director of Percheron Therapeutics James Garner Buys 40% More Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2628782122","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628782122?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:40","pubTimestamp":1776458444,"startTime":"0","endTime":"0","summary":"Whilst it may not be a huge deal, we thought it was good to see that the Percheron Therapeutics Limited ( ASX:PER...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-per/percheron-therapeutics-shares/news/ceo-md-director-of-percheron-therapeutics-james-garner-buys","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-per/percheron-therapeutics-shares/news/ceo-md-director-of-percheron-therapeutics-james-garner-buys","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK4196","MD","BK4139","BK7096","PER.AU","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627495171","title":"Percheron Therapeutics Ltd-Results of Entitlement Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627495171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627495171?lang=en_us&edition=fundamental","pubTime":"2026-04-14 11:00","pubTimestamp":1776135649,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUE1M3H2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624596158","title":"Bali Airport Records 1% Raise in Passengers During 2026 Eid Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=2624596158","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624596158?lang=en_us&edition=fundamental","pubTime":"2026-04-01 15:17","pubTimestamp":1775027866,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-I Gusti Ngurah Rai Airport in Bali served 1.14 million passengers during the 18-day Eid travel seasonin 2026.\"During the 18-day period of the integrated post from March 13 to 30, 2026, PT Angkasa Pura Indonesia, as the airport manager, recorded an overall 1.14 million passengers,\" said General Manager Nugroho Jati in a statement in Denpasar, Bali, on Tuesday.The airport, he said, recorded 503,000 domestic passengers and 639,000 passengers in international routes, a 1 percent raise compared to last year's Eid holiday season.","market":"sg","thumbnail":"https://statik.tempo.co/data/2026/03/04/id_1461974/1461974_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/03/04/id_1461974/1461974_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2095722/bali-airport-records-1-raise-in-passengers-during-2026-eid-holiday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2095722/bali-airport-records-1-raise-in-passengers-during-2026-eid-holiday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PER.AU","SUB","BK7096","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619482195","title":"BRIEF-Percheron Therapeutics To Raise Up To A$2.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619482195","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619482195?lang=en_us&edition=fundamental","pubTime":"2026-03-16 09:22","pubTimestamp":1773624136,"startTime":"0","endTime":"0","summary":"BRIEF-Percheron Therapeutics To Raise Up To A$2.2 MillionMarch 16  - Percheron Therapeutics Ltd PER.AX:NON-RENOUNCEABLE ENTITLEMENT OFFERANNOUNCES NON-RENOUNCEABLE ENTITLEMENT OFFER TO RAISE UP TO A$2.2 MILLIONISSUE PRICE SET AT A$0.005 PER SHAREFurther company coverage: PER.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUE4NW3M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619486221","title":"Percheron Therapeutics Ltd-Non-Renounceable Entitlement Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2619486221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619486221?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:59","pubTimestamp":1773615569,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE4NW3M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619486063","title":"Percheron Therapeutics Ltd - Issue Price Set at a$0.005 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2619486063","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619486063?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:59","pubTimestamp":1773615569,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE4NW3M4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}